MOLECULAR CHARACTERIZATION OF MUSCARINIC ACH RECEPTORS
毒蕈碱 ACH 受体的分子表征
基本信息
- 批准号:3402168
- 负责人:
- 金额:$ 12.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-09-23 至 1993-08-31
- 项目状态:已结题
- 来源:
- 关键词:affinity chromatography autoradiography biological signal transduction chemical binding chickens cow electron microscopy gel electrophoresis gene expression genetic library genetic transcription genetic translation glycosylation histochemistry /cytochemistry hybridomas immunochemistry ligands molecular weight monoclonal antibody muscarinic receptor neural conduction neural information processing neural plasticity neurogenesis posttranslational modifications protein sequence protein structure function receptor expression synapses
项目摘要
A 5-year molecular-level strategy is proposed for attacking an
important problem in vertebrate neurodevelopment: "How do CNS
neurons create postsynaptic zones specialized for proper signal
transduction?" The elementary activity of the brain is signaling
between cells -- mechanisms underlying development, maintenance
and plasticity of signal transduction are at the foundation of
brain function.
Muscarinic acetylcholine receptors have been selected as prototypes
for studying CNS postsynaptic specialization. These receptors are
implicated in a host of physiological and behavioral processes,
including conscious arousal, learning and memory. Moreover,
because Alzheimer's disease is associated with the death of ACh-
containing cells, new studies of cholinoceptive postsynaptic cells
could have considerable relevance to the public health.
The proposed work pursues fundamental questions stimulated by three
significant discoveries: (1) The CNS (but not heart) expresses a
novel 86 kDa "embryonic" type MAChR, abundant during neurite
growth, that developmentally down-regulates and is supplanted by
a 72 kDa "adult type" molecules; (2) In vivo, neurons stringently
regulate the placement of receptors, with all molecules localized
to dendrites even before synapses have formed; (3) Developing
neurons are "plastic" with respect to receptor placement and
expression of 86K/72K molecular types. These new and important
observations were made in studies of the chicken CNS, a widely-used
model for vertebrate neurodevelopment. Three specific aims have
been selected as most critical for expanding these findings:
(1) To establish the origin and structure of the 86 kDa and 72 kDa
receptor molecules by characterizing chicken receptor genes and
their transcription in the developing CNS.
(2) To determine where the 86K and 72K molecules are localized
relative to synaptic junctions, assessing possible mechanisms
underlying placement and plasticity.
(3) To compare the function of 86K and 72K receptors, investigating
possible novel growth-associated roles during the period of neurite
arborization and synaptogenesis.
提出了一个为期 5 年的分子水平战略来攻击
脊椎动物神经发育的一个重要问题:“中枢神经系统如何
神经元创建专门用于正确信号的突触后区域
转导?”大脑的基本活动是信号传导
细胞之间——发育、维持的机制
信号转导的可塑性和可塑性是
大脑功能。
毒蕈碱乙酰胆碱受体已被选为原型
用于研究中枢神经系统突触后专门化。 这些受体是
涉及许多生理和行为过程,
包括有意识的唤醒、学习和记忆。 而且,
因为阿尔茨海默病与乙酰胆碱的死亡有关
含有细胞,胆碱感受性突触后细胞的新研究
可能与公共卫生有很大关系。
拟议的工作追求由三个问题引发的基本问题
重大发现:(1)中枢神经系统(但不是心脏)表达
新颖的 86 kDa“胚胎”型 MAChR,在神经突期间丰富
生长,在发育过程中下调并被取代
72 kDa“成人型”分子; (2)在体内,神经元严格
调节受体的位置,所有分子都定位
甚至在突触形成之前就形成树突; (3) 开发中
神经元在受体位置方面是“可塑的”
86K/72K 分子类型的表达。 这些新的、重要的
在对鸡中枢神经系统的研究中进行了观察,鸡中枢神经系统是一种广泛使用的神经系统。
脊椎动物神经发育模型。 制定了三个具体目标
被选为扩展这些发现最关键的:
(1) 确定86 kDa和72 kDa的起源和结构
通过表征鸡受体基因和受体分子
它们在发育中的中枢神经系统中的转录。
(2) 确定86K和72K分子的定位位置
相对于突触连接,评估可能的机制
底层布局和可塑性。
(3)比较86K和72K受体的功能,研究
神经突期间可能具有与生长相关的新作用
树枝化和突触发生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM L KLEIN其他文献
WILLIAM L KLEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM L KLEIN', 18)}}的其他基金
Physiological role of naturally-occuring amyloid beta oligomers
天然存在的β淀粉样蛋白寡聚体的生理作用
- 批准号:
9759747 - 财政年份:2018
- 资助金额:
$ 12.65万 - 项目类别:
Development of a non-fibrillic amyloid-beta oligomer selective positron emission tomography imaging diagnostic for Alzheimer.
开发用于阿尔茨海默氏症的非纤维状淀粉样蛋白-β寡聚物选择性正电子发射断层扫描成像诊断。
- 批准号:
9202960 - 财政年份:2016
- 资助金额:
$ 12.65万 - 项目类别:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
一种用于早期阿尔茨海默病诊断的新型纳米粒子分子 MRI 探针
- 批准号:
8842908 - 财政年份:2014
- 资助金额:
$ 12.65万 - 项目类别:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
一种用于早期阿尔茨海默病诊断的新型纳米粒子分子 MRI 探针
- 批准号:
8683797 - 财政年份:2014
- 资助金额:
$ 12.65万 - 项目类别:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
使用独特的纳米技术平台发现阿尔茨海默病药物
- 批准号:
8548221 - 财政年份:2012
- 资助金额:
$ 12.65万 - 项目类别:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
使用独特的纳米技术平台发现阿尔茨海默病药物
- 批准号:
8446087 - 财政年份:2012
- 资助金额:
$ 12.65万 - 项目类别:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
ADDL、突触
- 批准号:
7615522 - 财政年份:2007
- 资助金额:
$ 12.65万 - 项目类别:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
ADDL、突触
- 批准号:
7184209 - 财政年份:2007
- 资助金额:
$ 12.65万 - 项目类别:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
ADDL、突触
- 批准号:
7470605 - 财政年份:2007
- 资助金额:
$ 12.65万 - 项目类别:
Abeta oligomers (ADDLs) in Alzheimers Disease pathology
阿尔茨海默病病理学中的 Abeta 寡聚物 (ADDL)
- 批准号:
6678227 - 财政年份:2003
- 资助金额:
$ 12.65万 - 项目类别:
相似海外基金
Development of non-contact autoradiography technology using magnetic field
利用磁场的非接触式放射自显影技术的开发
- 批准号:
19K15947 - 财政年份:2019
- 资助金额:
$ 12.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ultra High Resolution Brain PET Scanner for in-vivo Autoradiography Imaging
用于体内放射自显影成像的超高分辨率脑 PET 扫描仪
- 批准号:
9791189 - 财政年份:2018
- 资助金额:
$ 12.65万 - 项目类别:
Ultra High Resolution Brain PET Scanner for in-vivo Autoradiography Imaging
用于体内放射自显影成像的超高分辨率脑 PET 扫描仪
- 批准号:
10117728 - 财政年份:2018
- 资助金额:
$ 12.65万 - 项目类别:
Ultra High Resolution Brain PET Scanner for in-vivo Autoradiography Imaging
用于体内放射自显影成像的超高分辨率脑 PET 扫描仪
- 批准号:
10237144 - 财政年份:2018
- 资助金额:
$ 12.65万 - 项目类别:
Ultra High Resolution Brain PET Scanner for in-vivo Autoradiography Imaging
用于体内放射自显影成像的超高分辨率脑 PET 扫描仪
- 批准号:
10436281 - 财政年份:2018
- 资助金额:
$ 12.65万 - 项目类别:
Development of autoradiography technique capable of sequential imaging -Toward visualization of radioactive cesium dynamics in botanical bodies-
开发能够连续成像的放射自显影技术 -实现植物体中放射性铯动力学的可视化 -
- 批准号:
17K05109 - 财政年份:2017
- 资助金额:
$ 12.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
application of high resolution arufa-autoradiography for analysing micro-distribution of B-compund in tissues and its BNCT effects
应用高分辨率阿鲁法放射自显影分析B化合物在组织中的微观分布及其BNCT效应
- 批准号:
26670557 - 财政年份:2014
- 资助金额:
$ 12.65万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Visualization of the change in pain by the autoradiography and calcium imaging in the brain and spinal cord
通过放射自显影和大脑和脊髓钙成像显示疼痛变化
- 批准号:
24659294 - 财政年份:2012
- 资助金额:
$ 12.65万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Digital Autoradiography of an Irradiated Fuel Pellet
辐照燃料颗粒的数字放射自显影
- 批准号:
370568-2008 - 财政年份:2008
- 资助金额:
$ 12.65万 - 项目类别:
University Undergraduate Student Research Awards














{{item.name}}会员




